Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas.

Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas. Abstract Text:

    goshi nishimuraGoshi Nishimura,mamoru tsukudaMamoru Tsukuda,choichi horiuchiChoichi Horiuchi,kenichi satakeKenichi Satake,takafumi yoshidaTakafumi Yoshida,junichi nagaoJunichi Nagao,mariko kawakamiMariko Kawakami,norio kondoNorio Kondo,yasuhiro araiYasuhiro Arai,takahide taguchiTakahide Taguchi,hideki matsudaHideki Matsuda,yasukazu mikamiYasukazu Mikami,goshi nishimuraGoshi Nishimura,mamoru tsukudaMamoru Tsukuda,choichi horiuchiChoichi Horiuchi,kenichi satakeKenichi Satake,takafumi yoshidaTakafumi Yoshida,junichi nagaoJunichi Nagao,mariko kawakamiMariko Kawakami,norio kondoNorio Kondo,yasuhiro araiYasuhiro Arai,takahide taguchiTakahide Taguchi,hideki matsudaHideki Matsuda,yasukazu mikamiYasukazu Mikami,

    OBJECTIVES: Concurrent chemoradiotherapy (CCR) was given for the previously untreated T4 hypopharyngeal and laryngeal squamous cell carcinoma patients and the response and survival rates were evaluated. PATIENTS AND METHODS: A total of 23 patients, namely, 15 for hypopharynx and 8 for larynx were eligible. These patients were given cisplatin and 5-fluorouracil based chemotherapeutic regimens with conventional radiotherapy for a total dose of 66.6-70.2Gy. RESULTS: Ten out of the 15 hypopharyngeal carcinoma patients and 4 out of the 8 laryngeal carcinoma patients showed a complete response at the primary sites. The 5-year disease-specific survival rate was 59.4% in all the patients, 51.9% in the hypopharyngeal carcinoma patients, and 71.0% in the laryngeal patients. Seven out of the 12 resectable hypopharyngeal carcinoma patients and 4 out of 8 laryngeal carcinoma patients were able to do without total laryngectomy. CONCLUSIONS: Based on these results, the survival rate in the hypopharyngeal and laryngeal T4 carcinoma patients treated by CCR seems to be satisfactory and the possibility of organ preservation for the advanced patients is indicated.

    Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas. Publishing Authors By Initials

    g nishimuraG Nishimura,m tsukudaM Tsukuda,c horiuchiC Horiuchi,k satakeK Satake,t yoshidaT Yoshida,j nagaoJ Nagao,m kawakamiM Kawakami,n kondoN Kondo,y araiY Arai,t taguchiT Taguchi,h matsudaH Matsuda,y mikamiY Mikami,g nishimuraG Nishimura,m tsukudaM Tsukuda,c horiuchiC Horiuchi,k satakeK Satake,t yoshidaT Yoshida,j nagaoJ Nagao,m kawakamiM Kawakami,n kondoN Kondo,y araiY Arai,t taguchiT Taguchi,h matsudaH Matsuda,y mikamiY Mikami,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Auris, nasus, larynx

    VOLUME: 34

    Page Numbers: 499-504

    Journal Abbreviation:

    ISSN: 0385-8146

    DAY: 28

    MONTH: 06

    YEAR: 2007

    Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7708170

    Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas.

    AFFILIATION: Department of Otorhinolaryngology, Head and Neck Surgery, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan.

    Country: Netherlands

    Netherlands Research PublicationNetherlands Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Auris Nasus Larynx

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News